Eco Animal Health Group PLC Investor Presentation covering Interim Results
22 Noviembre 2022 - 1:00AM
RNS Non-Regulatory
TIDMEAH
Eco Animal Health Group PLC
22 November 2022
ECO Animal Health Group plc
("ECO" or the "Group") (AIM: EAH)
Investor Presentation covering Interim Results
ECO Animal Health Group plc, a leader in the development,
registration and marketing of pharmaceutical products for global
animal health markets, is pleased to announce that David Hallas,
CEO, and Christopher Wilks, CFO, will be conducting a live
presentation covering the Group's interim results for the period
ended 30 September 2022.
The online presentation will take place on Monday 28 November at
10.00 am UK time. This event is open to all existing and potential
shareholders and registration is free. Questions can be submitted
during the presentation and will be addressed at the end of it.
To register for the event, please click here
A video recording of the presentation will be available shortly afterwards here
Contacts:
ECO Animal Health Group plc
David Hallas (CEO)
Christopher Wilks (CFO) 020 8447 8899
IFC Advisory
Graham Herring
Zach Cohen 020 3934 6630
Singer Capital Markets (Nominated Adviser
& Joint Broker)
Mark Taylor
George Tzimas 020 7496 3000
Investec (Joint Broker)
Gary Clarence
Daniel Adams
Carlo Spingardi 020 7597 5970
Peel Hunt LLP (Joint Broker)
Dr Christopher Golden
James Steel 020 7418 8900
Equity Development
Hannah Crowe
Matt Evans 020 7065 2692
About ECO Animal Health
ECO Animal Health Group plc researches, develops and
commercialises products for livestock. Our business strategy is to
generate shareholder value by achieving the maximum sales potential
from the existing product portfolio whilst investing in Research
and Development ("R&D") for new products, particularly
vaccines, and seeking to in-license new products
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRABRBDBISDDGDB
(END) Dow Jones Newswires
November 22, 2022 02:00 ET (07:00 GMT)
Eco Animal Health (LSE:EAH)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Eco Animal Health (LSE:EAH)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024